Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04702737 |
|---|---|
| Brief Title: | A Study of Tarlatamab (AMG 757) in Participants With Neuroendocrine Prostate Cancer |
| First Submitted : | January 7, 2021 |
| First Submitted that Met QC Criteria : | January 7, 2021 |
| First Posted : | January 11, 2021 |
| Last Update Submitted that Met QC Criteria : | August 11, 2022 |
| Last Update Posted : | August 12, 2022 |